Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression
Author
McCubrey, James A.
Subject
Date
2017-12-06
Citation:
APA:
McCubrey, James A.. (December 2017).
Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression.
Oncotarget,
(8:68), p.113013-113033. Retrieved from
http://hdl.handle.net/10342/9628
MLA:
McCubrey, James A..
"Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression". Oncotarget.
8:68. (113013-113033.),
December 2017.
May 24, 2022.
http://hdl.handle.net/10342/9628.
Chicago:
McCubrey, James A.,
"Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression," Oncotarget 8, no.
68 (December 2017),
http://hdl.handle.net/10342/9628 (accessed
May 24, 2022).
AMA:
McCubrey, James A..
Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression. Oncotarget.
December 2017;
8(68)
113013-113033. http://hdl.handle.net/10342/9628. Accessed
May 24, 2022.
Collections